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HTLV-I and HTLV-II are endogenous and have shown
high prevalence rates among blood donors (1.4%), pregnant
women (1.1%), Guarani amerindians (5.8%), HIV-HTLV-I/
HTLV-II coinfected patients (16.3%) and spastic parapare-
tic individuals (21.6%) among indivividuals living in the city
of Porto Alegre, southern Brazil. Tropical spastic parapar-
esis/HTLV-I associated myelopathy is a immune-mediated
inflammatory disease in mid-thoracic spinal cord determin-
ing a myelopathy, with spastic-ataxic gait, intestinal and
micturitional disorders. No medication was proved to be a
disease modifying drug, just physical therapy and sympto-
matic management. No antiretroviral drug could benefit
the patients. Fampridine, a selective neuronal potassium
channel blocker, was licenced in USA and other countries,
since April 2010, for the treament of gait disorders in Mul-
tiple Sclerosis. Some clinical trials have shown some benefit
in patients with other kind of spinal cord diseases. Since
mid-2012 seven patients monoinfected by HTLV-I and
HAM/TSP are regularly using. Six of them improved in
ataxia, gait and strengh in the lower limbs. Micturictional
dysfunction improved in two. This off-label observational
experience offer a preliminary data for a broad discussion.
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